Patents Assigned to TIMA Foundation
-
Patent number: 9603847Abstract: Compositions and their use in the treatment or prevention of hyperglycemia and related diseases or disorders are disclosed.Type: GrantFiled: November 27, 2013Date of Patent: March 28, 2017Assignee: TIMA FoundationInventors: Markus Matuschka-Greiffenclau, Haruhiko Inufusa
-
Patent number: 9402849Abstract: The present invention is directed to a composition of matter, in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively. The composition of matter reduces the risk of neuropathy, neurodegenerative diseases including late-onset Alzheimer's disease, and cancer, in particular of pancreatic, esophageal, oropharyngolaryngeal, liver, colorectal, lung and/or breast cancer, in particular the drug and/or alcohol induced risk of said diseases. In this respect, the present invention is also directed to a composition of matter, in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively, which supports and/or moderates the alcohol degradation process within the human body.Type: GrantFiled: October 21, 2013Date of Patent: August 2, 2016Assignee: TIMA FOUNDATIONInventor: Markus Graf von Matuschka-Greiffenclau
-
Patent number: 9089548Abstract: The present invention relates to a composition consisting of Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin. The present invention relates further to the use of the composition for minimizing the cell-damaging effect of radicals and harmful forms of oxygen, in particular of oxygen radicals or reactive oxygen species. The present invention relates to a composition comprising Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin, wherein the composition is administered in a concentration ranging from 10 to 20 mg/kg body weight. The present invention relates further to the composition for use in the treatment and/or prevention of radical and harmful forms of oxygen derived diseases, in particular of oxygen radical or reactive oxygen species derived diseases. The present invention relates further to the composition as a food supplement or dietary supplement.Type: GrantFiled: November 15, 2012Date of Patent: July 28, 2015Assignee: Tima FoundationInventor: Haruhiko Inufusa
-
Publication number: 20140314731Abstract: The present invention relates to a composition consisting of Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin. The present invention relates further to the use of the composition for minimizing the cell-damaging effect of radicals and harmful forms of oxygen, in particular of oxygen radicals or reactive oxygen species. The present invention relates to a composition comprising Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin, wherein the composition is administered in a concentration ranging from 10 to 20 mg/kg body weight. The present invention relates further to the composition for use in the treatment and/or prevention of radical and harmful forms of oxygen derived diseases, in particular of oxygen radical or reactive oxygen species derived diseases. The present invention relates further to the composition as a food supplement or dietary supplement.Type: ApplicationFiled: November 15, 2012Publication date: October 23, 2014Applicant: TIMA FOUNDATIONInventor: Haruhiko Inufusa
-
Publication number: 20140105877Abstract: The present invention is directed to a composition of matter, in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively. The composition of matter reduces the risk of neuropathy, neurodegenerative diseases including late-onset Alzheimer's disease, and cancer, in particular of pancreatic, esophageal, oropharyngolaryngeal, liver, colorectal, lung and/or breast cancer, in particular the drug and/or alcohol induced risk of said diseases. In this respect, the present invention is also directed to a composition of matter, in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively, which supports and/or moderates the alcohol degradation process within the human body.Type: ApplicationFiled: October 21, 2013Publication date: April 17, 2014Applicant: Tima FoundationInventor: Markus Graf von MATUSCHKA-GREIFFENCLAU
-
Publication number: 20140086894Abstract: Compositions and their use in the treatment or prevention of hyperglycemia and related diseases or disorders are disclosed.Type: ApplicationFiled: November 27, 2013Publication date: March 27, 2014Applicant: TIMA FOUNDATIONInventors: Markus MATUSCHKA-GREIFFENCLAU, Haruhiko INUFUSA
-
Patent number: 8633192Abstract: Compositions and their use in the treatment or prevention of hyperglycemia and related diseases or disorders are disclosed.Type: GrantFiled: December 14, 2007Date of Patent: January 21, 2014Assignee: TIMA FoundationInventors: Markus Matuschka-Greiffenclau, Haruhiko Inufusa
-
Patent number: 8580750Abstract: The present invention is directed to a composition of matter, in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively. The composition of matter reduces the risk of neuropathy, neurodegenerative diseases including late-onset Alzheimer's disease, and cancer, in particular of pancreatic, esophageal, oropharyngolaryngeal, liver, colorectal, lung and/or breast cancer, in particular the drug and/or alcohol induced risk of said diseases. In this respect, the present invention is also directed to a composition of matter; in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively, which supports and/or moderates the alcohol degradation process within the human body.Type: GrantFiled: July 27, 2006Date of Patent: November 12, 2013Assignee: TIMA FoundationInventor: Markus Graf Von Matuschka-Greiffenclau
-
Patent number: 7886697Abstract: Described herein is a method of enhancing the reliability and reproducibility of animal experiments. As described herein, the method relates to an improved oral glucose tolerance test (OGTT) in animals, wherein the set up of the test has been optimized in comparison to the standard procedure for OGTT.Type: GrantFiled: December 6, 2007Date of Patent: February 15, 2011Assignee: TIMA FoundationInventor: Haruhiko Inufusa
-
Publication number: 20090221675Abstract: The present invention relates to a nucleic acid molecule encoding for IEX-1 polypeptide as a medicament. In a further aspect the present invention relates to a nucleic acid molecule encoding for IEX-1 polypeptide for the manufacture of a medicament for the treatment of gliomas.Type: ApplicationFiled: March 12, 2007Publication date: September 3, 2009Applicant: TIMA FOUNDATIONInventor: Markus Graf Matuschka Von Greiffenclau
-
Publication number: 20090145366Abstract: Described herein is a method of enhancing the reliability and reproducibility of animal experiments. As described herein, the method relates to an improved oral glucose tolerance test (OGTT) in animals, wherein the set up of the test has been optimized in comparison to the standard procedure for OGTT.Type: ApplicationFiled: December 6, 2007Publication date: June 11, 2009Applicant: TIMA FOUNDATIONInventor: Haruhiko INUFUSA
-
Publication number: 20090054351Abstract: The present invention is directed to a composition of matter, in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively. The composition of matter reduces the risk of neuropathy, neurodegenerative diseases including late-onset Alzheimer's disease, and cancer, in particular of pancreatic, esophageal, oropharyngolaryngeal, liver, colorectal, lung and/or breast cancer, in particular the drug and/or alcohol induced risk of said diseases. In this respect, the present invention is also directed to a composition of matter; in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively, which supports and/or moderates the alcohol degradation process within the human body.Type: ApplicationFiled: July 27, 2006Publication date: February 26, 2009Applicant: Tima FoundationInventor: Markus Graf Von Matuschka-Greiffenclau
-
Publication number: 20080161318Abstract: Compositions and their use in the treatment or prevention of hyperglycemia and related diseases or disorders are disclosed.Type: ApplicationFiled: December 14, 2007Publication date: July 3, 2008Applicant: TIMA FOUNDATIONInventors: Markus MATUSCHKA-GREIFFENCLAU, Haruhiko INUFUSA